Header Logo

Connection

Matthew Reynolds to United States

Back to Details
This is a "connection" page, showing publications Matthew Reynolds has written about United States.
Matthew Reynolds
Connection Strength
1.555
United States
  1. Zeitler EP, Bian B, Griffiths RI, Allocco DJ, Christen T, Roy K, Cohen DJ, Reynolds MR. Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2024 Oct; 17(10):e011007.
    View in: PubMed
    Score: 0.090
  2. Reynolds MR, Passman R, Swindle J, Mohammadi I, Wright B, Boyle K, Turakhia MP, Mittal S. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024 03; 269:25-34.
    View in: PubMed
    Score: 0.085
  3. Reynolds MR, Gong T, Li S, Herzog CA, Charytan DM. Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program. J Am Heart Assoc. 2021 04 06; 10(7):e019391.
    View in: PubMed
    Score: 0.070
  4. Sutton BS, Bermingham SL, Diamantopoulos A, Rosemas SC, Tsintzos SI, Xia Y, Reynolds MR. Economic value of insertable cardiac monitors in unexplained syncope in the United States. Open Heart. 2021 02; 8(1).
    View in: PubMed
    Score: 0.070
  5. Griffiths RI, Amorosi SL, Jacobsen CM, McBee PJ, Menzin J, Reynolds MR. Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2020 02; 31(2):503-511.
    View in: PubMed
    Score: 0.065
  6. Turakhia MP, Zweibel S, Swain AL, Mollenkopf SA, Reynolds MR. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks. Circ Cardiovasc Qual Outcomes. 2017 02; 10(2).
    View in: PubMed
    Score: 0.053
  7. Chyou JY, Hunter TD, Mollenkopf SA, Turakhia MP, Reynolds MR. Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients. J Am Heart Assoc. 2015 Jul 23; 4(7).
    View in: PubMed
    Score: 0.047
  8. Reynolds MR, Apruzzese P, Galper BZ, Murphy TP, Hirsch AT, Cutlip DE, Mohler ER, Regensteiner JG, Cohen DJ. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. J Am Heart Assoc. 2014 Nov 11; 3(6):e001233.
    View in: PubMed
    Score: 0.045
  9. Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Am J Ther. 2014 Nov-Dec; 21(6):500-8.
    View in: PubMed
    Score: 0.045
  10. Reynolds MR, Kamath AA, Grubb RL, Powers WJ, Adams HP, Derdeyn CP. The safety of aeroplane travel in patients with symptomatic carotid occlusion. J Neurol Neurosurg Psychiatry. 2014 Apr; 85(4):435-7.
    View in: PubMed
    Score: 0.042
  11. Reynolds MR, Floyd RG, Niileksela CR. How well is psychometric g indexed by global composites? Evidence from three popular intelligence tests. Psychol Assess. 2013 Dec; 25(4):1314-21.
    View in: PubMed
    Score: 0.041
  12. Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012 Dec 25; 60(25):2683-92.
    View in: PubMed
    Score: 0.039
  13. Kramer DB, Baker M, Ransford B, Molina-Markham A, Stewart Q, Fu K, Reynolds MR. Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance. PLoS One. 2012; 7(7):e40200.
    View in: PubMed
    Score: 0.038
  14. Reynolds MR, Panagos PD, Zipfel GJ, Lee JM, Derdeyn CP. Elements of a stroke center. Tech Vasc Interv Radiol. 2012 Mar; 15(1):5-9.
    View in: PubMed
    Score: 0.037
  15. Ladapo JA, David G, Gunnarsson CL, Hao SC, White SA, March JL, Reynolds MR. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol. 2012 Jan; 23(1):1-8.
    View in: PubMed
    Score: 0.036
  16. Kleinman NL, Rohrbacker NJ, White SA, March JL, Reynolds MR. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system. J Occup Environ Med. 2011 Apr; 53(4):405-14.
    View in: PubMed
    Score: 0.035
  17. Martin-Doyle W, Essebag V, Zimetbaum P, Reynolds MR. Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials. J Cardiovasc Electrophysiol. 2011 May; 22(5):548-53.
    View in: PubMed
    Score: 0.034
  18. Reynolds MR, Morais E, Zimetbaum P. Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: results from an observational registry. Am Heart J. 2010 Oct; 160(4):752-8.
    View in: PubMed
    Score: 0.034
  19. Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm. 2009 Sep; 6(9):1267-73.
    View in: PubMed
    Score: 0.031
  20. Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol. 2008 Dec 16; 52(25):2119-26.
    View in: PubMed
    Score: 0.030
  21. Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun; 18(6):628-33.
    View in: PubMed
    Score: 0.027
  22. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun 20; 47(12):2493-7.
    View in: PubMed
    Score: 0.025
  23. Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d'Avila A, Zimetbaum PJ, Yeh RW, Kramer DB. Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation. J Am Heart Assoc. 2025 Jan 21; 14(2):e037003.
    View in: PubMed
    Score: 0.023
  24. Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d'Avila A, Zimetbaum PJ, Yeh RW, Kramer DB. Outcomes of Atrial Fibrillation Ablation Among Older Adults in the United States: A Nationwide Study. JACC Clin Electrophysiol. 2024 Jul; 10(7 Pt 1):1341-1350.
    View in: PubMed
    Score: 0.022
  25. Reynolds MR, Josephson ME. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003 Oct 14; 108(15):1779-83.
    View in: PubMed
    Score: 0.021
  26. Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J. 2003 Feb; 145(2):334-42.
    View in: PubMed
    Score: 0.020
  27. Hsu JC, Reynolds MR, Song Y, Doros G, Lubitz SA, Gehi AK, Turakhia MP, Maddox TM. Outpatient Prescription Practices in Patients with Atrial Fibrillation (From the NCDR PINNACLE Registry). Am J Cardiol. 2021 09 15; 155:32-39.
    View in: PubMed
    Score: 0.018
  28. Barker CM, Reynolds MR, Reardon MJ, Van Houten JL, Murphy SME, Mollenkopf SA, Feldman TE. Relation of Institutional Mitral Valve Surgical Volume to Surgical and Transcatheter Outcomes in Medicare Patients. Am J Cardiol. 2021 05 15; 147:94-100.
    View in: PubMed
    Score: 0.017
  29. Resnic FS, Majithia A, Dhruva SS, Ssemaganda H, Robbins S, Marinac-Dabic D, Hewitt K, Ohno-Machado L, Reynolds MR, Matheny ME. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e006105.
    View in: PubMed
    Score: 0.016
  30. Barker CM, Reardon MJ, Reynolds MR, Feldman TE. Association Between Institutional Mitral Valve Procedure Volume and Mitral Valve Repair Outcomes in Medicare Patients. JACC Cardiovasc Interv. 2020 05 11; 13(9):1137-1139.
    View in: PubMed
    Score: 0.016
  31. Culler SD, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Brown PP, Schlosser ML, Simon AW. Understanding Readmissions in Medicare Beneficiaries During the 90-Day Follow-Up Period of an Acute Myocardial Infarction Admission. J Am Heart Assoc. 2019 11 05; 8(21):e013513.
    View in: PubMed
    Score: 0.016
  32. Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, Shen C, Choi E, Yeh RW. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J. 2019 07 14; 40(27):2231-2239.
    View in: PubMed
    Score: 0.016
  33. Culler SD, Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Schlosser ML, Simon AW. Impact of Complications on Resource Utilization During 90-Day Coronary Artery Bypass Graft Bundle for Medicare Beneficiaries. Ann Thorac Surg. 2019 May; 107(5):1364-1371.
    View in: PubMed
    Score: 0.015
  34. Lubitz SA, Khurshid S, Weng LC, Doros G, Keach JW, Gao Q, Gehi AK, Hsu JC, Reynolds MR, Turakhia MP, Maddox TM. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk. Am Heart J. 2018 06; 200:24-31.
    View in: PubMed
    Score: 0.014
  35. Culler SD, Cohen DJ, Brown PP, Kugelmass AD, Reynolds MR, Ambrose K, Schlosser ML, Simon AW, Katz MR. Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has?Transcatheter Aortic Valve Replacement?Made a Difference? Ann Thorac Surg. 2018 04; 105(4):1137-1143.
    View in: PubMed
    Score: 0.014
  36. Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018 03; 15(3):355-362.
    View in: PubMed
    Score: 0.014
  37. Baron SJ, Arnold SV, Reynolds MR, Wang K, Deeb M, Reardon MJ, Hermiller J, Yakubov SJ, Adams DH, Popma JJ, Cohen DJ. Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial. Am Heart J. 2017 Dec; 194:39-48.
    View in: PubMed
    Score: 0.014
  38. Chun KRJ, Brugada J, Elvan A, Gell?r L, Busch M, Barrera A, Schilling RJ, Reynolds MR, Hokanson RB, Holbrook R, Brown B, Schl?ter M, Kuck KH. The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial. J Am Heart Assoc. 2017 Jul 27; 6(8).
    View in: PubMed
    Score: 0.014
  39. Basil A, Lubitz SA, Noseworthy PA, Reynolds MR, Gold H, Yassa D, Kramer D. Periprocedural Antibiotic Prophylaxis for Cardiac Implantable Electrical Device Procedures: Results From a Heart Rhythm Society Survey. JACC Clin Electrophysiol. 2017 06; 3(6):632-634.
    View in: PubMed
    Score: 0.013
  40. Arnold SV, Spertus JA, Vemulapalli S, Li Z, Matsouaka RA, Baron SJ, Vora AN, Mack MJ, Reynolds MR, Rumsfeld JS, Cohen DJ. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry. JAMA Cardiol. 2017 04 01; 2(4):409-416.
    View in: PubMed
    Score: 0.013
  41. Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL. Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry. J Am Geriatr Soc. 2017 Feb; 65(2):340-347.
    View in: PubMed
    Score: 0.013
  42. Hatfield LA, Kramer DB, Volya R, Reynolds MR, Normand SL. Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure. J Am Heart Assoc. 2016 07 28; 5(8).
    View in: PubMed
    Score: 0.013
  43. Nazarian S, Reynolds MR, Ryan MP, Wolff SD, Mollenkopf SA, Turakhia MP. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. 2016 Jan; 43(1):115-27.
    View in: PubMed
    Score: 0.012
  44. Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46.
    View in: PubMed
    Score: 0.012
  45. Pinto DS, Kohli P, Fan W, Kirtane AJ, Kociol RD, Meduri C, Deliargyris EN, Prats J, Reynolds MR, Stone GW, Michael Gibson C. Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database. Catheter Cardiovasc Interv. 2016 Feb 15; 87(3):363-73.
    View in: PubMed
    Score: 0.012
  46. Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323.
    View in: PubMed
    Score: 0.011
  47. Culler SD, Kugelmass AD, Brown PP, Reynolds MR, Simon AW. Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012. Circulation. 2015 Jan 27; 131(4):362-70; discussion 370.
    View in: PubMed
    Score: 0.011
  48. Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL, Douglas PS, Svensson LG, Gada H, Thourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv. 2014 Dec; 7(6):829-36.
    View in: PubMed
    Score: 0.011
  49. Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014 Sep 23; 130(13):1037-43.
    View in: PubMed
    Score: 0.011
  50. Kaufman AS, Zhou X, Reynolds MR, Kaufman NL, Green GP, Weiss LG. The possible societal impact of the decrease in U.S. blood lead levels on adult IQ. Environ Res. 2014 Jul; 132:413-20.
    View in: PubMed
    Score: 0.011
  51. Voigt J, Sasha John M, Taylor A, Krucoff M, Reynolds MR, Michael Gibson C. A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol. 2014 May; 37(5):312-21.
    View in: PubMed
    Score: 0.011
  52. Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014 Jun 15; 113(12):2052-6.
    View in: PubMed
    Score: 0.011
  53. Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Mar 04; 63(8):788-96.
    View in: PubMed
    Score: 0.011
  54. Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol. 2014 Jul 15; 64(2):182-92.
    View in: PubMed
    Score: 0.011
  55. Murphy TP, Reynolds MR, Cohen DJ, Regensteiner JG, Massaro JM, Cutlip DE, Mohler ER, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Hirsch AT. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol. 2013 Oct; 24(10):1427-35; quiz 1436.
    View in: PubMed
    Score: 0.010
  56. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97.
    View in: PubMed
    Score: 0.010
  57. Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013 Apr; 10(4):e59-65.
    View in: PubMed
    Score: 0.010
  58. Amin AP, Reynolds MR, Lei Y, Magnuson EA, Vilain K, Durtschi AJ, Simonton CA, Stone GW, Cohen DJ. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial). Am J Cardiol. 2012 Sep 15; 110(6):765-70.
    View in: PubMed
    Score: 0.010
  59. Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol. 2010 Aug 31; 56(10):766-73.
    View in: PubMed
    Score: 0.008
  60. Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010 Sep; 7(9):1340-5.
    View in: PubMed
    Score: 0.008
  61. Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol. 2008 Nov 25; 52(22):1758-68.
    View in: PubMed
    Score: 0.007
  62. Culler SD, Simon AW, Brown PP, Kugelmass AD, Reynolds MR, Rask KJ. Sex differences in hospital risk-adjusted mortality rates for Medicare beneficiaries undergoing CABG surgery. Arch Intern Med. 2008 Nov 24; 168(21):2317-22; discussion 2323-5.
    View in: PubMed
    Score: 0.007
  63. Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008 Jun; 85(6):1980-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.